Getagraph.com logo
S&P 500
(-1.42%) 4 999.81 points
Dow Jones
(-1.31%) 37 956 points
Nasdaq
(-2.29%) 15 353 points
Oil
(-0.08%) $82.74
Gas
(-0.85%) $1.639
Gold
(-0.33%) $2 330.60
Silver
(-0.35%) $27.25
Platinum
(-0.68%) $909.60
USD/EUR
(0.17%) $0.936
USD/NOK
(0.27%) $11.01
USD/GBP
(0.01%) $0.803
USD/RUB
(-0.05%) $92.28

Realtime updates for Herantis Pharma Oyj [HRTIS.HE]

Exchange: HEL Sector: Healthcare Industry: Biotechnology
Last Updated25 Apr 2024 @ 08:46
25% discount on Stockinvest.us - Use code: Podcast

-5.35% € 1.415

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 08:46):

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD...

Stats
Today's Volume 13 381.00
Average Volume 9 877.00
Market Cap 28.53M
EPS €0 ( 2024-03-06 )
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E 70.75
ATR14 €0.0160 (1.13%)

Volume Correlation

Long: 0.19 (neutral)
Short: -0.69 (moderate negative)
Signal:(43.545) Neutral

Herantis Pharma Oyj Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Herantis Pharma Oyj Correlation - Currency/Commodity

The country flag 0.40
( neutral )
The country flag 0.33
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.23
( neutral )

Herantis Pharma Oyj Financials

Annual 2023
Revenue: €0
Gross Profit: €0 (0.00 %)
EPS: €0.0163
Q4 2023
Revenue: €0
Gross Profit: €0 (0.00 %)
EPS: €0.120
Q2 2023
Revenue: €0
Gross Profit: €0 (0.00 %)
EPS: €-0.110
Q1 2023
Revenue: €0
Gross Profit: €0 (0.00 %)
EPS: €-0.0550

Financial Reports:

No articles found.

Herantis Pharma Oyj

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD. The company was incorporated in 2008 and is based in Espoo, Finland.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators